Viraferonpeg and injection site reaction Patient Reports February 11, 2012

Viraferonpeg Side Effects Report #5455179-X
Viraferonpeg side effect was reported by a Physician from FRANCE on Sept 05, 2007. Male patient, 54 years of age, weighting 189.6 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: injection site reaction, panniculitis, skin necrosis. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, AMARYL, GLUCOPHAGE, THERALENE. Patient recovered.

Viraferonpeg Side Effects Report #5361371-5
Viraferonpeg side effect was reported by a Physician from FRANCE on June 04, 2007. Male patient, 53 years of age, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: injection site reaction, panniculitis, skin ulcer. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient recovered.

Viraferonpeg Side Effects Report #5441502-9
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 17, 2007. Male patient, 43 years of age, was diagnosed with hepatitis c , neuropathy peripheral and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: injection site reaction, pruritus, rash maculo-papular, toxic skin eruption. Viraferonpeg dosage: unknown. During the same period patient was treated with COPEGUS, LYRICA, REYATAZ, KALETRA, LAROXYL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4652554-8
Viraferonpeg side effect was reported by a Physician from on Apr 22, 2005. Male patient, 33 years of age, weighting 183.0 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: injection site necrosis, injection site reaction, necrotising panniculitis, pain in extremity, scab , skin necrosis, ulcer . Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.


Viraferonpeg Side Effects Report #4883104-9
Viraferonpeg side effect was reported by a Physician from FRANCE on Jan 05, 2006. Male patient, 33 years of age, weighting 183.0 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: erythema, feeling hot, injection site necrosis, injection site reaction, lymphadenopathy, necrotising panniculitis, oedema peripheral, pain in extremity, post procedural complication. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4551826-5
Viraferonpeg side effect was reported by a Physician from on Dec 31, 2004. Female patient, 40 years of age, was diagnosed with chronic hepatitis and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: arthralgia, hyperaesthesia, inflammation, influenza, injection site reaction, myalgia, pain of skin. Viraferonpeg dosage: 0.5 ML SUBCUTANEOUS. During the same period patient was treated with REBETOL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4562817-2
Viraferonpeg side effect was reported by a Physician from on Jan 13, 2005. Male patient, 40 years of age, weighting 231.5 lb, was diagnosed with chronic hepatitis and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: hyperaesthesia, inflammation, influenza like illness, injection site reaction, skin test positive. Viraferonpeg dosage: 0.5 ML SUBCUTANEOUS. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4664772-3
Viraferonpeg side effect was reported by a Physician from on May 12, 2005. Male patient, 40 years of age, weighting 231.5 lb, was diagnosed with chronic hepatitis and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: arthralgia, erythema, headache , hyperaesthesia, hyperthermia, inflammation, influenza, injection site reaction, myalgia. Viraferonpeg dosage: 0.5 ML SUBCUTANEOUS. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.